Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  362 results for ""Histocompatibility Antigens Class I""

Your Filters

Subject : melanoma
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants.

  • Authors : Stopfer LE; Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139.; Gajadhar AS

Subjects: Antigen Presentation/Antigen Presentation/Antigen Presentation/*immunology ; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*analysis ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Sep 14; Vol. 118 (37).Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.

  • Authors : Qi YA; Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA. Electronic address: .; Maity TK

Subjects: Adenocarcinoma of Lung/Adenocarcinoma of Lung/Adenocarcinoma of Lung/*metabolism ; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*metabolism ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*metabolism

  • Source: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2021; Vol. 20, pp. 100136. Date of Electronic Publication: 2021 Aug 13.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.

  • Authors : Ferrari de Andrade L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. .; Department of Immunology, Harvard Medical School, Boston, Massachusetts.

Subjects: Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*chemistry ; Immunity, Cellular/Immunity, Cellular/Immunity, Cellular/*immunology ; Killer Cells, Natural/Killer Cells, Natural/Killer Cells, Natural/*immunology

  • Source: Cancer immunology research [Cancer Immunol Res] 2020 Jun; Vol. 8 (6), pp. 769-780. Date of Electronic Publication: 2020 Mar 24.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition.

  • Authors : Lee JH; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia.

Subjects: Cell Differentiation* ; Down-Regulation* ; Transcriptome*

  • Source: Nature communications [Nat Commun] 2020 Apr 20; Vol. 11 (1), pp. 1897. Date of Electronic Publication: 2020 Apr 20.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir.

  • Authors : Callahan BM; Department of Molecular Medicine, Morsani College of Medicine, Tampa, Florida.; Patel JS

Subjects: Mutation*; Cytoskeletal Proteins/Cytoskeletal Proteins/Cytoskeletal Proteins/*metabolism ; Endopeptidases/Endopeptidases/Endopeptidases/*metabolism

  • Source: International journal of cancer [Int J Cancer] 2018 Mar 01; Vol. 142 (5), pp. 988-998. Date of Electronic Publication: 2017 Nov 02.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.

  • Authors : Kalaora S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Wolf Y

Subjects: Antigen Presentation/Antigen Presentation/Antigen Presentation/*immunology ; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*immunology ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*immunology

  • Source: Cancer discovery [Cancer Discov] 2018 Nov; Vol. 8 (11), pp. 1366-1375. Date of Electronic Publication: 2018 Sep 12.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.

  • Authors : Ferrari de Andrade L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.

Subjects: Antibodies, Blocking/Antibodies, Blocking/Antibodies, Blocking/*therapeutic use ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*immunology

  • Source: Science (New York, N.Y.) [Science] 2018 Mar 30; Vol. 359 (6383), pp. 1537-1542.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.

  • Authors : Chowell D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Subjects: CTLA-4 Antigen/CTLA-4 Antigen/CTLA-4 Antigen/*antagonists & inhibitors ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*genetics ; Immunotherapy/Immunotherapy/Immunotherapy/*methods

  • Source: Science (New York, N.Y.) [Science] 2018 Feb 02; Vol. 359 (6375), pp. 582-587. Date of Electronic Publication: 2017 Dec 07.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.

  • Authors : Cao J; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Conjunctival Neoplasms/Conjunctival Neoplasms/Conjunctival Neoplasms/*metabolism ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*metabolism

  • Source: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2018 Feb 01; Vol. 59 (2), pp. 1005-1015.Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.

  • Authors : Ghorani E; Cancer Immunology Unit, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London, London, UK.

Subjects: Adenocarcinoma of Lung/Adenocarcinoma of Lung/Adenocarcinoma of Lung/*genetics ; Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/Histocompatibility Antigens Class I/*genetics ; Melanoma/Melanoma/Melanoma/*genetics

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Jan 01; Vol. 29 (1), pp. 271-279.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic)

Record details

Read More Add to Saved list
×
  • 1-10 of  362 results for ""Histocompatibility Antigens Class I""